Key biomarkers within the colorectal cancer related inflammatory microenvironment

Valentin Calu1,2, Adriana Ionescu3, Loredana Stanca4

  • 1Department of General Surgery, University of Medicine and Pharmacy "Carol Davila" Bucharest, 8 Blvd., Eroii Sanitari, 050474, Bucharest, Romania.

Scientific Reports
|April 13, 2021
PubMed

Insights

Researchers identified key inflammation biomarkers in colorectal cancer (CRC) tissues. Decreased APRIL and increased BAFF, IL8, and MMP2 levels were tumor-specific, offering potential therapeutic targets for CRC.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • The tumor microenvironment's inflammatory aspects are crucial in colorectal cancer (CRC) progression.
  • Understanding specific biomolecules involved can lead to novel therapeutic strategies.

Purpose of the Study:

  • To analyze and identify inflammation-associated biomolecules in CRC tumor tissues compared to normal tissues.
  • To explore correlations between these biomolecules, tumor stage, and immune infiltrate.

Main Methods:

  • Analysis of tumor and normal tissues from 22 CRC patients.
  • Multiplex immunoassay for 39 inflammation biomarkers.
  • ELISA for CEA and CA19-9.
  • Western blot for occludin, pErk, STAT1, and STAT3.
  • Histopathological evaluation for tumor staging.

Main Results:

  • 32 biomarkers showed significant differences between tumor and normal tissues.
  • Positive correlations found between MMP2-IL8 and BAFF-IL8.
  • Negative correlations observed for APRIL with MMP2, BAFF, and IL8.
  • APRIL, BAFF, IL8, and MMP2 levels inversely correlated with immune infiltrate and CD163 expression, independent of tumor stage.

Conclusions:

  • Significantly decreased APRIL and increased BAFF, IL8, and MMP2 expression are tumor-specific in CRC.
  • These specific biomarkers warrant further investigation for developing new CRC treatments.
  • Correlations suggest roles for Chitinase 3-like 1, IL8, and MMP2 in tumor growth and metastasis.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
523
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
482